IBT B — Infant Bacterial Therapeutics AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK1.23bn
- SEK899.53m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -47.2 | -71.9 | -44.6 | -65.8 | -135 |
Depreciation | |||||
Non-Cash Items | -5.04 | 14.8 | -19.3 | -33.3 | 2.07 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.127 | -2.11 | 7.4 | 12.5 | 30.5 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -51.3 | -58.4 | -55.6 | -85.8 | -101 |
Financing Cash Flow Items | 0 | — | — | -0.02 | -5.03 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 1.76 | 0.091 | 1.88 | 96.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -47 | -71.8 | -36.7 | -50.9 | -6.78 |